Jorge Mestre-Ferrandiz
Publications and Insights
- Publication: The Value of Knowing and Knowing the Value: Improving the Health Technology Assessment of Complementary Diagnostics
- Publication: Dementia: The R&D Landscape
- Publication: Multi-indication Pricing: Pros, Cons and Applicability to the UK
- Publication: The Expanding Value Footprint of Oncology Treatments
- Publication: The Current Drug Development Paradigm: Responding to US and European Demands for Evidence of Comparative Effectiveness and Relative Effectiveness
- Publication: What is the Role of HTA for Biosimilars?
- Publication: Projecting Expenditure on Medicines in the NHS: Second Edition
- Publication: Projecting Expenditure on Medicines in the NHS
- Publication: The R&D Cost of a New Medicine
- Publication: International Comparisons of Medicines Prices: 2011 Indices
- Publication: The Many Faces of Innovation
- Publication: Assessment of the Impact of Orphan Medicinal Products on the European Economy and Society
- Publication: Researching the Relative Efficacy and Relative Effectiveness of Medicines across Europe
- Publication: Access Mechanisms for Orphan Drugs: A Comparative Study of Selected European Countries
- Publication: Forward Together: Complementarity of Public and Charitable Research with Respect to Private Research Spending
- Publication: European Medicines Pricing and Reimbursement: Now and the Future
- Publication: The Faces of Regulation: Profit and Price Regulation of the UK Pharmaceutical Industry after the 1998 Competition Act
- Publication: Institutions for Industrial Competitiveness in the International Pharmaceutical Industry